Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $85 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a price target of $85.
January 16, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel reaffirmed an Overweight rating on Encompass Health with a price target of $85, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a reputable analyst suggests a positive sentiment towards Encompass Health's stock. The maintained price target of $85 implies that the analyst believes the stock has the potential to reach or exceed this value in the short term, which could influence investor confidence and drive the stock price upward.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100